Premenstrual dysphoric disorder: is it simply PMS?

Author： Endicott J.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 259-259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Duloxetine for premenstrual dysphoric disorder: a pilot study

By Mazza Marianna   Harnic Desiree   Catalano Valeria   Janiri Luigi   Bria Pietro  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 4, 2008-03 ,pp. : 517-521

Informa Healthcare

Access to resources Recommend Favorite

Luteal Phase Administration of Agents for the Treatment of Premenstrual Dysphoric Disorder

By Freeman E.W.  

CNS Drugs, Vol. 18, Iss. 7, 2004-01 ,pp. : 453-468

Adis International

Access to resources Recommend Favorite

Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder

By Yonkers Kimberly A   Pearlstein Teri  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 979-991

Informa Healthcare

Access to resources Recommend Favorite

Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline

By Halbreich Uriel   Kahn Linda S  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. : 2065-2078

Informa Healthcare

Access to resources Recommend Favorite

Effects of Antidepressants on Quality of Life in Women with Premenstrual Dysphoric Disorder

By Freeman Ellen W.  

PharmacoEconomics, Vol. 23, Iss. 5, 2005-01 ,pp. : 433-444

Adis International

Access to resources Recommend Favorite